|
Market Cap (17-May) $522,816,704 (439th) |
Close (30-Jun) $4.40 |
Volume (30-Jun) 565,229 |
Shortsold (5-May) 2,410,503 (2.97%) (86th) |
|
52w High $7.31 |
52w Low $3.74 |
P/E 285.71 |
EPS -1.56 |
MYX released this announcement to the ASX on 19 August 2022, 8:33. The announcement is marked as price sensitive, and is 2 page(s) in length and 147.48kb in size.
You can view all announcements from MYX and see how they appear on a price chart on the announcements page.
At the date of this announcement, MYX was 3.401% short sold according to ASIC data. It was ranked the 69th most shorted stock on the ASX. It remains ranked 86th as of the latest reported data (05 May 2025).
| Other Recent Announcements from MYX | |
|---|---|
| Notification of cessation of securities - MYX | 30 June 2023, 16:11 |
| Update - Notification of buy-back - MYX | 30 June 2023, 8:19 |
| Update - Notification of buy-back - MYX | 29 June 2023, 8:20 |
| Mayne Pharma CEO announces plan to retire | 19 August 2022, 8:33 |
| Ceasing to be a substantial holder | 10 August 2022, 18:38 |
| Mayne Pharma announces sale of Metrics Contract Services | 10 August 2022, 8:21 |
| FDA approval of HALOETTE, a generic version of NUVARING | 8 August 2022, 8:06 |
You must be logged in to post a reply.
Mayne Pharma Group 